MedPath

Exploratory study of a new method of plasma moxibustion for the treatment of insomnia

Phase 1
Conditions
insomnia
Registration Number
ITMCTR2200005749
Lead Sponsor
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medicine Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

? Patients who presented with insomnia as the main complaint, met the above diagnostic criteria, and had a typical symptom group of insomnia.
? Identification and typing belong to deficiency symptoms.
? PSQI = 8 points.
? 18-65 years of age.
? Voluntarily participate in this study, cooperate with blood sampling and laboratory tests twice (10 ml each time), and sign informed consent.

Exclusion Criteria

? Those with actual manifestations of TCM identification.
? Those with combined diseases that have not been effectively controlled or are extremely serious, such as persistent pain from various causes, malignant tumors, cardiovascular diseases, neuroendocrine diseases, neuromuscular diseases and gastrointestinal diseases that cause insomnia disorders.
? Patients with severe depression and psychosis.
? Patients who are pregnant and breastfeeding.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pittsburgh sleep quality index,PSQI;
Secondary Outcome Measures
NameTimeMethod
Gastrointestinal Symptom Rating Scale, GSRS;Hamilton Anxiety Scale,HAMA;HamiltonDepressionScale,HAMD;
© Copyright 2025. All Rights Reserved by MedPath